|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Jun―23 |
Cytokine fingerprint differences following infection and vaccination - what can we learn from COVID-19? |
Shira Cohen Rubin, Nadav Zacks, Ori Wand, Ophir Freund, Evgeni Gershman, Anna Breslavsky, et al. (+4) Rotem Givoli-Vilensky, Anat Tzurel Ferber, Natalya Bilenko, Amir Bar-Shai |
2 |
[GO] |
2023―Sep―19 |
Effect of interferon-α on COVID-19 in-hospital mortality: a large-scale propensity score-matched study |
Mohamad Amin Pourhoseingholi, Amirreza Rafiei Javazm, Naghmeh Asadimanesh, Fatemeh Shojaeian, Mehdi Azizmohammad Looha, Seyed Amir Ahmad Safavi-Naini, et al. (+7) Benyamin Mohammadzadeh, Parnian Jamshidi, Fatemeh Gholampoor, Omid Yazdani, Nadia Zameni, Zahra Azizan, Amirhossein Sahebkar |
3 |
[GO] |
2022―Oct―21 |
Th1 cytokine endotype discriminates and predicts severe complications in COVID-19 |
|
4 |
[GO] |
2021―Aug―04 |
Interleukin 17 antagonist netakimab is effective and safe in the new coronavirus infection (COVID-19) |
Roman Maslennikov, Vladimir Ivashkin, Ekaterina Vasilieva, Maxim Chipurik, Polina Semikova, Victoria Semenets, et al. (+6) Tatyana Russkova, Anna Levshina, Diana Grigoriadis, Shamil Magomedov, Irina Efremova, Natiya Dzhakhaya |
5 |
[GO] |
2021―Mar―02 |
Extensive longitudinal immune profiling reveals sustained innate immune activaton in COVID-19 patients with unfavorable outcome |
Benjamin Schrijver, Jorn L.J.C. Assmann, Adriaan J. van Gammeren, Roel C.H. Vermeulen, Lützen Portengen, Peter Heukels, et al. (+4) Anton W. Langerak, Willem A. Dik, Vincent H.J. van der Velden, Ton A.A.M. Ermens |
6 |
[GO] |
2020―Dec―28 |
Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality |
Negar Moradian, Mahdi Gouravani, Mohammad Amin Salehi, Arash Heidari, Melika Shafeghat, Michael R. Hamblin, Nima Rezaei |
7 |
[GO] |
2020―Sep―18 |
Interleukin-6 and severe COVID-19: a systematic review and meta-analysis |
Helia Mojtabavi, Amene Saghazadeh, Nima Rezaei |